glp-1 weight loss oral solution directions Liquid Therapy for Metabolic & Health Personalized GLP-1 | Safe &

Glucagon-like peptide-1 receptor agonists in type 2 diabetes: a meta-analysis of randomized clinical trials

DEXA/CT, dual-energy X-ray absorptiometry/computed tomography

The drug is known as a triple-agonist, meaning it targets three different receptors in the brain and throughout the body

Simon TG, Roelstraete B, Hagstrm H, Sundstrm J, Ludvigsson JF

There is also a bigger ongoing study with over 2,000 people to confirm these results and gather more information, which will continue for about 89 weeks

GLP-1 medications have emerged as a valuable addition to the arsenal of treatments for type 2 diabetes, offering benefits such as improved blood sugar control, weight loss, and cardiovascular protection